首页> 外文期刊>Bone marrow transplantation >Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
【24h】

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

机译:造血细胞移植后长期存活者的推荐筛查和预防措施

获取原文
获取原文并翻译 | 示例
       

摘要

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (for example, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri- and post-transplant exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplant experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This report provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.
机译:造血细胞移植(HCT)技术和支持性护理技术的进步已导致HCT术后长期生存的改善。出现新的移植适应症,引入较新的移植物来源(例如脐带血)以及使用强度较低的调节方案移植老年患者也有助于增加HCT幸存者的数量。这些幸存者面临着因移植前,移植后和移植后暴露以及危险因素而继发晚期并发症的风险。 2006年发布了针对HCT幸存者的筛查和预防措施的指南。2011年,国际移植专家组召开会议,回顾了当代文献并更新了建议,同时考虑了不断变化的移植实践和这些指南的国际适用性。本报告提供了针对自体和异基因HCT的儿科和成年幸存者进行筛查和预防措施的最新建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号